Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02260440 |
|---|---|
| Brief Title: | A Phase 2 Study of Pembrolizumab (MK-3475) in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal Cancer |
| First Submitted : | October 6, 2014 |
| First Submitted that Met QC Criteria : | October 6, 2014 |
| First Posted : | October 9, 2014 (Estimate) |
| Results First Submitted : | April 10, 2017 |
| Results First Submitted that Met QC Criteria : | April 10, 2017 |
| Results First Posted : | May 16, 2017 |
| Last Update Submitted that Met QC Criteria : | September 9, 2019 |
| Last Update Posted : | September 17, 2019 |